Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of Multitarget tDCS for Neuropathic Pain

NCT: NCT06510725 · COMPLETED

NCT IDNCT06510725
StatusCOMPLETED
Start Date2024-09-01
Completion2026-08-25
SponsorXuanwu Hospital, Beijing (OTHER)
First posted
Last updated

Brief Summary

This study aims to conduct a randomized controlled trial to evaluate the effect of multitarget transcranial direct current stimulation (tDCS) on pain, depression, anxiety, quality of life and sleep, in patients with neuropathic pain.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑